The transcription factor Sox7 modulates endocardiac cushion formation contributed to atrioventricular septal defect through Wnt4/Bmp2 signaling.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
12 04 2021
Historique:
received: 15 11 2020
accepted: 22 03 2021
entrez: 13 4 2021
pubmed: 14 4 2021
medline: 13 10 2021
Statut: epublish

Résumé

Cardiac septum malformations account for the largest proportion in congenital heart defects. The transcription factor Sox7 has critical functions in the vascular development and angiogenesis. It is unclear whether Sox7 also contributes to cardiac septation development. We identified a de novo 8p23.1 deletion with Sox7 haploinsufficiency in an atrioventricular septal defect (AVSD) patient using whole exome sequencing in 100 AVSD patients. Then, multiple Sox7 conditional loss-of-function mice models were generated to explore the role of Sox7 in atrioventricular cushion development. Sox7 deficiency mice embryos exhibited partial AVSD and impaired endothelial to mesenchymal transition (EndMT). Transcriptome analysis revealed BMP signaling pathway was significantly downregulated in Sox7 deficiency atrioventricular cushions. Mechanistically, Sox7 deficiency reduced the expressions of Bmp2 in atrioventricular canal myocardium and Wnt4 in endocardium, and Sox7 binds to Wnt4 and Bmp2 directly. Furthermore, WNT4 or BMP2 protein could partially rescue the impaired EndMT process caused by Sox7 deficiency, and inhibition of BMP2 by Noggin could attenuate the effect of WNT4 protein. In summary, our findings identify Sox7 as a novel AVSD pathogenic candidate gene, and it can regulate the EndMT involved in atrioventricular cushion morphogenesis through Wnt4-Bmp2 signaling. This study contributes new strategies to the diagnosis and treatment of congenital heart defects.

Identifiants

pubmed: 33846290
doi: 10.1038/s41419-021-03658-z
pii: 10.1038/s41419-021-03658-z
pmc: PMC8041771
doi:

Substances chimiques

BMP2 protein, human 0
Bone Morphogenetic Protein 2 0
SOX7 protein, human 0
SOXF Transcription Factors 0
Sox7 protein, mouse 0
WNT4 protein, human 0
Wnt4 Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

393

Références

Virani, S. S. et al. Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation 141, e139–e596 (2020).
pubmed: 31992061 doi: 10.1161/CIR.0000000000000757
Wolf, M. & Basson, C. T. The molecular genetics of congenital heart disease: a review of recent developments. Curr. Opin. Cardiol. 25, 192–197 (2010).
pubmed: 20186050 pmcid: 2930935 doi: 10.1097/HCO.0b013e328337b4ce
Bruneau, B. G. The developmental genetics of congenital heart disease. Nature 451, 943–948 (2008).
pubmed: 18288184 doi: 10.1038/nature06801
Hoffman, J. I., Kaplan, S. & Liberthson, R. R. Prevalence of congenital heart disease. Am. Heart J. 147, 425–439 (2004).
pubmed: 14999190 doi: 10.1016/j.ahj.2003.05.003
Reller, M. D., Strickland, M. J., Riehle-Colarusso, T., Mahle, W. T. & Correa, A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998–2005. J. Pediatr. 153, 807–813 (2008).
pubmed: 18657826 pmcid: 2613036 doi: 10.1016/j.jpeds.2008.05.059
Christensen, N. et al. Atrioventricular septal defects among infants in Europe: a population-based study of prevalence, associated anomalies, and survival. Cardiol. Young-. 23, 560–567 (2013).
pubmed: 23182167 doi: 10.1017/S1047951112001400
Eisenberg, L. M. & Markwald, R. R. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ. Res. 77, 1–6 (1995).
pubmed: 7788867 doi: 10.1161/01.RES.77.1.1
Wu, B. et al. Nfatc1 coordinates valve endocardial cell lineage development required for heart valve formation. Circ. Res. 109, 183–192 (2011).
pubmed: 21597012 pmcid: 3132827 doi: 10.1161/CIRCRESAHA.111.245035
Zhang, H., Lui, K. O. & Zhou, B. Endocardial cell plasticity in cardiac development, diseases and regeneration. Circ. Res. 122, 774–789 (2018).
pubmed: 29496799 doi: 10.1161/CIRCRESAHA.117.312136
Olson, E. N. & Srivastava, D. Molecular pathways controlling heart development. Science 272, 671–676 (1996).
pubmed: 8614825 doi: 10.1126/science.272.5262.671
Lefebvre, V., Dumitriu, B., Penzo-Méndez, A., Han, Y. & Pallavi, B. Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int. J. Biochem. Cell. Biol. 39, 2195–2214 (2007).
pubmed: 17625949 pmcid: 2080623 doi: 10.1016/j.biocel.2007.05.019
Gandillet, A. et al. Sox7-sustained expression alters the balance between proliferation and differentiation of hematopoietic progenitors at the onset of blood specification. Blood 114, 4813–4822 (2009).
pubmed: 19801444 doi: 10.1182/blood-2009-06-226290
Francois, M., Koopman, P. & Beltrame, M. Sox F genes: key players in the development of the cardio-vascular system. Int. J. Biochem. Cell. Biol. 42, 445–448 (2010).
pubmed: 19733255 doi: 10.1016/j.biocel.2009.08.017
Kim, K. et al. Sox F transcription factors are positive feedback regulators of VEGF signaling. Circ. Res. 119, 839–852 (2016).
pubmed: 27528602 doi: 10.1161/CIRCRESAHA.116.308483
Lilly, A. J., Mazan, A., Scott, D. A., Lacaud, G. & Kouskoff, V. SOX7 expression is critically required in FLK1-expressing cells for vasculogenesis and angiogenesis during mouse embryonic development. Mech. Dev. 146, 31–41 (2017).
pubmed: 28577909 pmcid: 5496588 doi: 10.1016/j.mod.2017.05.004
Cermenati, S. et al. Sox18 and Sox7 play redundant roles in vascular development. Blood 111, 2657–2666 (2008).
pubmed: 18094332 doi: 10.1182/blood-2007-07-100412
Lilly, A. J. et al. Interplay between SOX7 and RUNX1 regulates hemogenic endothelial fate in the yolk sac. Development 143, 4341–4351 (2016).
pubmed: 27802172
Wat, M. J. et al. Mouse model reveals the role of SOX7 in the development of congenital diaphragmatic hernia associated with recurrent deletions of 8p23.1. Hum. Mol. Genet. 21, 4115–4125 (2012).
pubmed: 22723016 pmcid: 3428158 doi: 10.1093/hmg/dds241
Calkoen, E. E. et al. Atrioventricular septal defect: from embryonic development to long-term follow-up. Int. J. Cardiol. 202, 784–795 (2016).
pubmed: 26476030 doi: 10.1016/j.ijcard.2015.09.081
Camenisch, T. D. et al. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Investig. 106, 349–360 (2000).
pubmed: 10930438 doi: 10.1172/JCI10272 pmcid: 314332
Liu, F., Guo, L., Xin, G. & Wang, Z. miR-452 promotes cell metastasis and the epithelial to mesenchymal by targeting SOX7 in clear-cell renal-cell carcinoma. J. Cell. Biochem. 120, 8401–8408 (2018).
doi: 10.1002/jcb.28125
Akiyama, H. et al. Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc. Natl Acad. Sci. USA 101, 6502–6507 (2004).
pubmed: 15096597 doi: 10.1073/pnas.0401711101 pmcid: 404074
Boogerd, K. J. et al. Msx1 and Msx2 are functional interacting partners of T-box factors in the regulation of Connexin43. Cardiovasc. Res. 78, 485–493 (2018).
doi: 10.1093/cvr/cvn049
Shirai, M., Imanaka-Yoshida, K., Schneider, M. D., Schwartz, R. J. & Morisaki, T. T-box 2, a mediator of Bmp-Smad signaling, induced hyaluronan synthase 2 and Tgfbeta2 expression and endocardial cushion formation. Proc. Natl Acad. Sci. USA 106, 18604–18609 (2009).
pubmed: 19846762 doi: 10.1073/pnas.0900635106 pmcid: 2773962
Armstrong, E. J. & Bischoff, J. Heart valve development: endothelial cell signaling and differentiation. Circ. Res. 95, 459–470 (2004).
pubmed: 15345668 pmcid: 2810618 doi: 10.1161/01.RES.0000141146.95728.da
Wang, Y. et al. Endocardial to myocardial Notch–Wnt–Bmp axis regulates early heart valve development. PLoS ONE 8, e60244 (2013).
pubmed: 23560082 pmcid: 3613384 doi: 10.1371/journal.pone.0060244
Nakajima, Y., Yamagishi, T., Hokari, S. & Nakamura, H. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat. Rec. 258, 119–127 (2000).
pubmed: 10645959 doi: 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U
Délot, E. C. Control of endocardial cushion and cardiac valve maturation by BMP signaling pathways. Mol. Genet. Metab. 80, 27–35 (2003).
pubmed: 14567955 doi: 10.1016/j.ymgme.2003.07.004
Patel, S. S. et al. Analysis of selected maternal exposures and non-syndromic atrioventricular septal defects in the National Birth Defects Prevention Study, 1997-2005. Am. J. Med. Genet. A 158, 2447–2455 (2012).
doi: 10.1002/ajmg.a.35555
Gittenberger-de Groot, A. C., Calkoen, E. E., Poelmann, R. E., Bartelings, M. M. & Jongbloed, M. R. Morphogenesis and molecular considerations on congenital cardiac septal defects. Ann. Med. 46, 640–652 (2014).
pubmed: 25307363 doi: 10.3109/07853890.2014.959557
Ballarati, L. et al. Genotype-phenotype correlations in a new case of 8p23.1 deletion and review of the literature. Eur. J. Med. Genet. 54, 55–59 (2011).
pubmed: 20969981 doi: 10.1016/j.ejmg.2010.10.003
Wat, M. J. et al. Chromosome 8p23.1 deletion as a cause of complex congenital heart defects and diaphragmatic hernia. Am. J. Med. Genet. 149, 1661–1677 (2009).
doi: 10.1002/ajmg.a.32896
Li, W. J. et al. Association between the PPP1R3B polymorphisms and serum lipid traits, the risk of coronary artery disease and ischemic stroke in a southern Chinese Han population. Nutr. Metab. 15, 27 (2018).
doi: 10.1186/s12986-018-0266-y
Pennington, S. M. et al. Defective protein repair under methionine sulfoxide a deletion drives autophagy and ARE-dependent gene transcription. Redox Biol. 16, 401–413 (2018).
pubmed: 29649787 pmcid: 5953240 doi: 10.1016/j.redox.2018.04.001
Takash, W. et al. SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling. Nucleic Acids Res. 29, 4274–4283 (2001).
pubmed: 11691915 pmcid: 60197 doi: 10.1093/nar/29.21.4274
Katoh, M. Expression of human SOX7 in normal tissues and tumors. Int. J. Mol. Med. 9, 363–368 (2002).
pubmed: 11891528
Zhang, H. et al. Genetic lineage tracing identifies endocardial origin of liver vasculature. Nat. Genet. 48, 537–543 (2016).
pubmed: 27019112 doi: 10.1038/ng.3536
Santos, R. et al. Conditional creation and rescue of Nipbl-deficiency in mice reveals multiple determinants of risk for congenital heart defects. PLoS Biol. 14, e2000197 (2016).
pubmed: 27606604 pmcid: 5016002 doi: 10.1371/journal.pbio.2000197
Ma, L., Lu, M. F., Schwartz, R. J. & Martin, J. F. Bmp2 is essential for cardiac cushion epithelial–mesenchymal transition and myocardial patterning. Development 132, 5601–5611 (2005).
pubmed: 16314491 doi: 10.1242/dev.02156
Yao, H. H. et al. Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev. Dyn. 230, 210–215 (2004).
pubmed: 15162500 pmcid: 4046253 doi: 10.1002/dvdy.20042
Wu, B. et al. Endocardial cells form the coronary arteries by angiogenesis through myocardial-endocardial VEGF signaling. Cell 151, 1083–1096 (2012).
pubmed: 23178125 pmcid: 3508471 doi: 10.1016/j.cell.2012.10.023
Zhang, H. et al. Yap1 is required for endothelial to mesenchymal transition of the atrioventricular cushion. J. Biol. Chem. 289, 18681–18692 (2014).
pubmed: 24831012 pmcid: 4081914 doi: 10.1074/jbc.M114.554584
Vincentz, J. W. et al. An absence of Twist1 results in aberrant cardiac neural crest morphogenesis. Dev. Biol. 320, 131–139 (2008).
pubmed: 18539270 pmcid: 2572997 doi: 10.1016/j.ydbio.2008.04.037
Hong, N. et al. A loss-of-function mutation p.T52S in RIPPLY3 is a potential predisposing genetic risk factor for Chinese Han conotruncal heart defect patients without the 22q11.2 deletion/duplication. J. Transl. Med. 16, 260 (2018).
pubmed: 30241482 pmcid: 6151064 doi: 10.1186/s12967-018-1633-1
Niimi, T., Hayashi, Y., Futaki, S. & Sekiguchi, K. SOX7 and SOX17 regulate the parietal endoderm-specific enhancer activity of mouse laminin alpha1 gene. J. Biol. Chem. 279, 38055–38061 (2004).
pubmed: 15220343 doi: 10.1074/jbc.M403724200

Auteurs

Nanchao Hong (N)

Department of Pediatric Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 200092, Shanghai, China.
Department of Cardiology, Shanghai Institute of Cardiovascular Disease, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.

Erge Zhang (E)

Department of Pediatric Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 200092, Shanghai, China.

Huilin Xie (H)

Department of Pediatric Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 200092, Shanghai, China.
Department of Cardiology, Shanghai Institute of Cardiovascular Disease, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.

Lihui Jin (L)

Department of Pediatric Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 200092, Shanghai, China.

Qi Zhang (Q)

Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, 200092, Shanghai, China.

Yanan Lu (Y)

Department of Pediatric Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 200092, Shanghai, China.

Alex F Chen (AF)

Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, 200092, Shanghai, China.

Yongguo Yu (Y)

Department of Pediatric Endocrinology and Genetic Metabolism, Shanghai Institute for Pediatric Research, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 200092, Shanghai, China.

Bin Zhou (B)

Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 200031, Shanghai, China.

Sun Chen (S)

Department of Pediatric Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 200092, Shanghai, China. chensun@xinhuamed.com.cn.

Yu Yu (Y)

Department of Pediatric Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 200092, Shanghai, China. yuyu@xinhuamed.com.cn.
Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, 200092, Shanghai, China. yuyu@xinhuamed.com.cn.

Kun Sun (K)

Department of Pediatric Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 200092, Shanghai, China. sunkun@xinhuamed.com.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH